BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
Keyword: Steatotic liver disease
1
Steatotic liver disease in patients with chronic hepatitis C
12/26/2025 10:27:32 AM | Browse: 24 | Download: 66
2
Genetic predeterminants and recent advancements in steatotic liver disease: A roadmap toward precision hepatology
11/27/2025 7:53:58 AM | Browse: 33 | Download: 105
3
Cytokeratin 18 fragment is associated with steatosis-associated fibrosis estimator score and lipid in patients with steatotic liver disease
11/27/2025 7:53:53 AM | Browse: 20 | Download: 73
4
Microbiome and gut-liver interactions: From mechanisms to therapies
10/27/2025 8:08:12 AM | Browse: 115 | Download: 146
5
Impact of metabolic endoscopy on fibrosis regression in steatotic liver disease
9/25/2025 11:24:01 AM | Browse: 87 | Download: 105
6
Are we standing on the shifting sands of post-transplant metabolic-associated steatotic liver disease?
7/25/2025 12:09:47 PM | Browse: 110 | Download: 299
7
Triglyceride-glucose-waist circumference index: A powerful tool for metabolic dysfunction-associated steatotic liver disease
7/25/2025 12:09:44 PM | Browse: 65 | Download: 273
8
Evaluating the RESET care program: Advancing towards scalable and effective healthcare solutions for metabolic dysfunction-associated liver disease
4/25/2025 8:22:59 AM | Browse: 99 | Download: 330
9
Disparities in Liver Transplantation for Metabolic Dysfunction-Associated Steatohepatitis (MASH)-Associated Hepatocellular Carcinoma
4/18/2025 8:22:03 AM | Browse: 88 | Download: 478
10
Patterns of dietary supplement use among United States patients with steatotic liver disease: Vitamins, minerals and botanicals
3/26/2025 4:06:51 AM | Browse: 69 | Download: 430
11
Effect of alpha-lipoic acid and Silybum marianum supplementation with a Mediterranean diet on metabolic dysfunction-associated steatosis
1/6/2025 8:47:56 AM | Browse: 79 | Download: 572
12
Hepatitis B virus infection and metabolic dysfunction associated steatotic liver disease: Rising pandemic with complex interaction
1/6/2025 8:47:56 AM | Browse: 86 | Download: 416
13
Elafibranor, a dual PPARα and PPARδ agonist, reduces alcohol-associated liver disease: Lessons from a mouse model
12/30/2024 6:47:30 AM | Browse: 75 | Download: 384
14
Clinical profiles and their interaction of concurrent metabolic associated steatotic liver disease and hepatitis B virus infection
11/29/2024 2:50:17 PM | Browse: 200 | Download: 670
15
Alanine aminotransferase predicts incident steatotic liver disease of metabolic etiology. Long life to the old biomarker !
6/25/2024 10:41:21 AM | Browse: 155 | Download: 707
16
Sarcopenia and metabolic dysfunction associated steatotic liver disease: Time to address both
6/20/2024 3:42:22 AM | Browse: 178 | Download: 489
17
Changes in the terminology and diagnostic criteria of non-alcoholic fatty liver disease: Implications and opportunities
4/19/2024 3:18:01 AM | Browse: 110 | Download: 549
18
Liver biopsy in the post-hepatitis C virus era in Japan
4/12/2024 4:45:44 PM | Browse: 148 | Download: 755
Write to the Help Desk
© 2004-2026 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

California Corporate Number: 3537345